Real World Efficacy and Toxicity of Selinexor: Importance of Patient Characteristics, Dose Intensity and Post Progression Outcomes.
Kastritis E, Gavriatopoulou M, Solia E, Theodorakakou F, Spiliopoulou V, Malandrakis P, Ntanasis-Stathopoulos I, Migkou M, Kokkali N, Eleutherakis-Papaiakovou E, Syrigou R, Fotiou D, Terpos E, Dimopoulos MA.
Kastritis E, et al. Among authors: solia e.
Clin Lymphoma Myeloma Leuk. 2023 Nov;23(11):844-849. doi: 10.1016/j.clml.2023.07.013. Epub 2023 Aug 1.
Clin Lymphoma Myeloma Leuk. 2023.
PMID: 37599164